1. Long, R., et al., Relative versus absolute
noncontagiousness of respiratory tuberculosis on treatment. Infect
Control Hosp Epidemiol, 2003. 24(11): p. 831-8.
2. Moore, D.F., et al., Amplification of
rRNA for assessment of treatment response of pulmonary tuberculosis
patients during antimicrobial therapy. J Clin Microbiol, 1996.
34(7): p. 1745-9.
3. Telzak, E.E., et al., Factors influencing
time to sputum conversion among patients with smear-positive pulmonary
tuberculosis. Clin Infect Dis, 1997. 25(3): p. 666-70.
4. Iinuma, Y., et al., Diagnostic value of
the Amplicor PCR assay for initial diagnosis and assessment of
treatment response for pulmonary tuberculosis. Microbiol Immunol,
1998. 42(4): p. 281-7.
5. Iseman, M.D., An unholy trinity--three
negative sputum smears and release from tuberculosis isolation.
Clin Infect Dis, 1997. 25(3): p. 671-2.
6. Department of Human Services, Victoria.,
Management, Control and Prevention of tuberculosis.
Guidelines for health care providers (2002 - 2005).
7. Guidelines for preventing the transmission
of tuberculosis in Canadian Health Care Facilities and other institutional
settings. Can Commun Dis Rep, 1996. 22 Suppl 1: p. i-iv, 1-50,
i-iv, 1-55.
8. Guidelines for preventing the transmission
of Mycobacterium tuberculosis in health-care facilities, 1994.
Centers for Disease Control and Prevention. MMWR Recomm Rep, 1994.
43(RR-13): p. 1-132.
9. Control and prevention of tuberculosis
in the United Kingdom: code of practice 2000. Joint Tuberculosis
Committee of the British Thoracic Society. Thorax, 2000. 55(11):
p. 887-901.
